CONTENTS

 

 

BIOLOGICAL RESEARCH

 

 

 

Prokhorov A.S., Golygina S.E., Sakharov A.V.(Chita, Moscow) Prognostic value of chemokines in the first episode of paranoid schizophrenia before the start of antipsychotic therapy……………………………………………………...

Ershova E.S., Chudakova Yu.M., Veiko N.N., Martynov A.V., Kostyuk S.E., Kostyuk S.V., Balakireva E.E., Shushpanova O.V., Nikitina S.G., Blinova T.E., Shalina N.S., Koval-Zaitsev A.A., Ivanov M.V.(Moscow) Variations in the content of satellite III (1q12) and ribosomal repeat in the DNA of blood leukocytes of children with autism spectrum disorders during therapy……………………………………………………………………………………...

 

5

 

 

 

17

 

 

CLINICAL PSYCHIATRY

 

 

 

Sheremetyeva I.I., Stroganov A.E., Kandrina N.V., Plotnikov A.V., Kuleshova E.O.(Barnaul) An integrated approach to the treatment of neurotic disorders in participants of the Special Military Operation…………………

 

27

 

 

PENITENTIARY PSYCHIATRY

 

 

 

Makushkina O.A., Frolova A.V., Leurda E.V., Sharabidze N.G. (Moscow) Clinical aspects of behavioral dysregulation in individuals with schizophrenia who have committed socially dangerous acts……………………

 

36

 

 

CHILD AND ADOLESCENT PSYCHIATRY

 

 

 

Shushpanova O.V., Golubeva N.I., Balakireva E.E., Nikitina S.G., Blinova T.E., Shalina N.S.(Moscow) Clinical features of depressive disorders in childhood and adolescence…………………………………………………….

 

47

 

 

LECTURES. REVIEWS

 

 

 

Kibitov A.O., Shumskaya D.S.(St. Petersburg)Modern genome-wide association studies of mental disorders: focus on the mechanisms of inflammation………………………………………………………………………………

 

56

 

 

PSYCHOPHARMACOTHERAPY

 

 

 

Shushpanova T.V., Kupriyanova I.E., Mandel A.I., Kazennykh T.V., Novozheeva T.P., Schastnyy E.D.,

Perchatkina O.E., Kisel N.I., Ukraintsev I.I., Smirnova I.N., Zaitsev A.A., Selivanov G.Yu., Vasilieva O.A.(Tomsk, St. Petersburg) Effect of pharmacotherapy on the pharmacokinetic parameters of the model substrate antipyrine ‒ a test evidence of the processes of xenobiotic elimination in saliva in patients with mental disorders………

 

 

 

66

 

 

ORGANIZATION OF PSYCHIATRIC CARE

 

 

 

Shport S.V., Makushkina O.A. (Moscow) Psychiatric care for the population of the Russian Federation: resource provision and dynamics of indicators………………………………………………………………………………….

 

82

 

 

CLINICAL PSYCHOLOGY

 

 

 

Smirnova N.S., Simutkin G.G., Surovtseva A.K., Vasilieva S.N., Didenko E.V. (Tomsk) Dynamic assessment of executive function disorders in patients with recurrent depressive disorder and bipolar affective disorder during psychopharmacotherapy……………………………………………………………………………………………………

 

 

97

 

 

EPILEPTOLOGY

 

 

 

Tokareva N.G., Ignatieva O.I.(Saransk) Impact of interictal headache on the quality of life in patients with epilepsy……………………………………………………………………………………………………………….

 

104

 

 

COMORBIDITY OF MENTAL DISORDERS

 

 

 

Serov O.A., Tursunova N.V., Zhukova E.M.(Novosibirsk)Influence of tobacco smoking on the development of mental disorders in patients with tuberculosis

 

111

 

 

Zarubina N.V.(Moscow, Yaroslavl) Influence of depressive disorders on the personality characteristics of patients with multiple sclerosis ………………………………………………………………………………………………….

 

119

 

 

SHPAP AUTHOR INDEX FOR 2024………………………………………………………………………………

129